Regulation of B lymphocyte differentiation

Annals of Allergy, Asthma and Immunology

Volumn 84, Issue 4, 2000, Pages

  Jelinek, Diane F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CYTOKINE; DIACYLGLYCEROL; FC RECEPTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INOSITOL TRISPHOSPHATE; INTERLEUKIN 13; INTERLEUKIN 4; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C; PROTEIN KINASE C;

B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; GENE; GERMINAL CENTER; HUMAN; HYPERSENSITIVITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0343729889     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1081-1206(10)62267-3     Document Type: Review

References (87)

1. Rossi GL, Olivieri D. Does the mast cell still have a key role in asthma? Chest 1997;112:523-529.
2. Kinet J-P. The high affinity IgE receptor (Fc∈RI): from physiology to pathology. Ann Rev Immunol 1999;17: 931-972.
3. Maurer D, Ebner C, Reininger B, et al. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol 1995; 154:6285-6290.
4. Maurer D, Fiebiger S, Ebner C, et al. Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol 1996;157: 607-616.
5. Armitage RJ, Goff LK. Functional interaction between B cell subpopulations defined by CD23 expression. Eur J Immunol 1988;18:1753-1760.
6. Buckley C, Rustin MH, Ivison C, et al. Differentiation and CD23 expression of peripheral blood monocytes in patients with atopic dermatitis. Br J Derm 1995;133:757-763.
7. Aubry JP, Pochon S, Graber P, et al. CD21 is a ligand for CD23 and regulates IgE production. Nature 1992;358: 505-507.
8. Mudde GC, Bheekha R, Bruijnzeel-Koomen CAFM. IgE-mediated antigen presentation. Allergy 1995;50: 193-199.
9. Kehry MR, Yamashita LC. Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing. Proc Natl Acad Sci USA 1989;86:7556-7560.
10. Oettgen HC, Martin TR, Wynshaw-Boris A, et al. Active anaphylaxis in IgE-deficient mice. Nature 1994;370: 367-370.
11. Ujike A, Ishikawa Y, Ono M, et al. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J Exp Med 1999;189:1573-1579.
12. Dombrowicz D, Lin S, Flamand V, et al. Allergy-associated FcRβR is a molecular amplifier of IgE- and IgG-mediated in vivo responses. Immunity 1998;8:517-529.
13. Opstelten D, Osmond DG. Pre-B cells in the bone marrow: immunofluorescence stathmokinetic studies of the proliferation of cytoplasmic mu-chain bearing cells in normal mice. J Immunol 1983;131:2635-2640.
14. Gordon MY, Barrett MJ. Bone marrow disorders. In: The biological basis of clinical problems. London: Blackwell Scientific Publications, 1985.
15. Rosenberg N, Kincade PW. B-lineage differentiation in normal and transformed cells and the microenvironment that supports it. Curr Opin Immunol 1994;6:203-211.
16. th edition, New York: Raven Press, 1998.
17. Croce CM, Shander M, Martinis J, et al. Chromosomal location of the genes for human immunoglobulin heavy chains. Proc Natl Acad Sci USA 1979; 76:3416-3419.
18. McBride OW, Hieter PA, Hollis GF, et al. Chromosomal location of human kappa and lambda immunoglobulin light chain constant region genes. J Exp Med 1982;155:1480-1490.
19. Wu TT, Kabat EA. An analysis of the sequences of the variable regions of Bence-Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med 1970;132:211-250.
20. Ravetch JV, Siebenlist U, Korsmeyer SJ, et al. Structure of the human immunoglobulin mu locus; characterization of embryonic and rearranged J and D genes. Cell 1981;27:583-591.
21. nd edition. Oxford: IRL Press, 1995.
22. Tonegawa S, Maxam AM, Tizard R, et al. Sequence of a mouse germ-line gene for a variable region of an immunoglobulin light chain gene. Proc Natl Acad Sci USA 1978;75:1485-1489.
23. Reth M, Gehrmann P, Petrac E, et al. A novel VH to VHDJH joining mechanism in heavy-chain-negative (null) pre-B cells results in heavy chain production. Nature 1986;322:840-842.
24. Reth MG, Ammirati P, Jackson S, et al. Regulated progression of a cultured pre-B cell line to the B-cell stage. Nature 1985;317:353-355.
25. Hombach J, Tsubata T, Leclercq L, et al. Molecular components of the B cell antigen receptor complex of the IgM class. Nature 1990;343:760-762.
26. Van Noesel CJM, Borst J, DeVries EFR, et al. Identification of two distinct phosphoproteins as components of the human B cell antigen receptor complex. Eur J Immunol 1990;20: 2789-2793.
27. Papavasiliou F, Misulovin Z, Suh H, et al. The role of Igβ in precursor B cell transition and allelic exclusion. Science 1995;268:408-411.
28. Torres RM, Flaswinkel H, Reth M, et al. Aberrant B cell development and immune response in mice with a compromised BCR complex. Science 1996;272:1804-1808.
29. Campbell KS. Signal transduction from the B cell antigen receptor. Curr Op Immunol 1999;11:256-264.
30. Kurosaki T. Genetic analysis of B cell antigen receptor signaling. Annu Rev Immunol 1999;17:555-592.
31. Reth M. Antigen receptor tail clue. Nature 1989;338:383-384.
32. Gold MR, Matsuuchi L, Kelly R, et al. Tyrosine phosphorylation of components of the B cell antigen receptors following receptor crosslinking. Proc Natl Acad Sci USA 1991;88: 3436-3438.
33. Justement LB, Campbell KS, Chien NC, et al. Regulation of B cell antigen receptor signal transduction and phosphorylation by CD45. Science 1991; 252:1839-1842.
34. Kurosaki T, Takata M, Yamanashi Y, et al. Syk activation by the Src-family tyrosine kinase in the B cell antigen receptor signaling. J Exp Med 1994; 179:1725-1729.
35. Law C-L, Chandran KA, Sidorenko SP, et al. Phopholipase C-γl interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol Cell Biol 1996;16:1305-1315.
36. Crespo P, Schuebel KE, Ostrom AA, et al. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 1997;385:169-172.
37. Li N, Batzer A, Daly R, et al. Guaninenucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signaling. Nature 1993;363:85-88.
38. Liu Y-J, Arpin C, de Bouteiller O, et al. Sequential triggering of apoptosis, somatic mutation, and isotype switch during germinal center development. Sem Immunol 1996;8:169-177.
39. Pabst R, Gehrke I. Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans? Am J Respir Cell Mol Biol 1990;3:131-135.
40. Gould SJ, Isaacson PG. Bronchus-associated lymphoid tissue (BALT) in human fetal and infant lung. J Pathol 1993;169:229-234.
41. Chvatchki Y, Kosco-Vilbois MH, Herren S, et al. Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway challenge. J Exp Med 1996;184: 2353-2360.
42. Tarlinton D. Germinal centers: form and function. Curr Opin Immunol 1998;10:245-251.
43. Hess J, Laumen H, Muller B, et al. Molecular genetics of the germinal center reaction. J Cell Physiol 1998; 177:525-534.
44. Griffiths GM, Berek C, Kaartinen M, et al. Somatic mutation and the maturation of immune response to 2-phenyl oxazolone. Nature 1984;312:271-275.
45. Neuberger MS, Milstein C. Somatic hypermutation. Curr Opin Immunol 1995;7:248-254.
46. Wabl MR, Forni L, Loor F. Switch in immunoglobulin class production observed in single clones of committed lymphocytes. Science 1978;199: 1078-1080.
47. Stavnezer J. Immunoglobulin class switching. Curr Opin Immunol 1996; 8:199-205.
48. Kataoka T, Miyata T, Honjo T. Repetitive sequences in class switch recombination regions of immunoglobulin heavy chain genes. Cell 1981;23: 357-368.
49. Isakson PC, Pure E, Vitetta ES, et al. T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. J Exp Med 1982;155: 734-748.
50. Allen RC, Armitage RJ, Conley ME, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993;259:990-993.
51. Ramesh N, Seki M, Notarangelo LD, et al. The hyper-IgM (HIM) syndrome. Springer Semin Immunopathol 1998; 19:383-389.
52. Grewell IS, Flavell RA. The role of CD40 ligand in costimulation and T-cell activation. Immunol Rev 1996; 153:85-106.
53. Paulie S, Ehlin-Henriksson, Mellstedt H, et al. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Can Immunol Immunother 1985;20:23-28.
54. Banchereau J, Bazan F, Blanchard D, et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994;12:881-922.
55. Westendorf JJ, Ahmann GJ, Armitage RJ, et al. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J Immunol 1994; 152:117-128.
56. Armitage RJ, Fanslow WC, Strockbine L, et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992;357:80-82.
57. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. New Eng J Med 1998;338:1813-1820.
58. Lederman S, Yellin MJ, Inghirami G, et al. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J Immunol 1992;149: 3817-3826.
59. Casamajor-Palleja M, Khan M, MacLennon ICM. A subset of CD4+ memory T cells contain preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J Exp Med 1995;181: 1293-1301.
60. Butch AW, Chung G-H, Hoffmann JW, et al. Cytokine expression by germinal center cells. J Immunol 1993; 150:39-47.
61. Kelsoe G. The germinal center: a crucible for lymphocyte selection. Sem Immunol 1996;8:179-184.
62. Shan H, Shlomchik M, Weigert M. Heavy-chain class switch does not terminate somatic mutation. J Exp Med 1990;172:531-536.
63. Jacob J, Kelsoe G. In-situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl) acetyl II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers. J Exp Med 1992; 176:679-687.
64. Wykes M, Pombo B, Jenkins C, et al. Dendritic cells interact directly with naïve B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J Immunol 1998;161:1313-1319.
65. Dubois B, Massacrier C, Vanbervliet B, et al. Critical role of IL-12 in dendritic cell-induced differentiation of naïve B lymphocytes. J Immunol 1998;161:2223-2231.
66. Snapper CM, Marcu KB, Zelazowski P. The immunoglobulin class switch: beyond "accessibility." Immunity 1997;6:217-223.
67. Kuhn R, Rajewsky K, Muller W. Generation and analysis of interleukin-4 deficient mice. Science 1991;254: 707-710.
68. Shimoda K, van Deursen J, Sangster MY, et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996;380:630-633.
69. Punnonen J, Aversa G, Cocks BG. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993;90: 730-734.
70. Blaser K. Allergen dose dependent cytokine production regulates specific IgE and IgG antibody production. Adv Exp Med Med Biol 1996;409: 295-303.
71. Parronchi P, Macchia D, Piccinni MP, et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991;88:4538-4542.
72. Kamogawa Y, Minasi LA, Carding SR, et al. The relationship of IL-4 and IFN-γ producing T cells studied by lineage ablation of IL-4 producing cells. Cell 1993;75:985-995.
73. Coffman R, Carty, J. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-γ. J Immunol 1986;136:949-954.
74. Snapper CJ, Paul WE. Interferon-γ and B cell stimulatory factor-I reciprocally regulate Ig isotype production. Science 1987;236:944-947.
75. Gascan H, Gauchat JF, Roncaolo MG, et al. Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones. J Exp Med 1991; 173:747-752.
76. van der Zee JS, van Swieten P, Aalberse RC. Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency. J Immunol 1986;137:3566-3571.
77. Rihet P, Demeure CE, Dessein AJ, et al. Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area. Eur J Immunol 1992;22:2063-2070.
78. Ohashi Y, Nakai H, Okamoto H, et al. Significant correlation between symptom score and IgG4 antibody titer following long-term immunotherapy for perennial allergic rhinitis. Ann Otol Rhinol Laryngol 1997;106:483-489.
79. de Garcia-Robaina JC, la Torre-Morin F, Vazquez-Moncholi C, et al. The natural history of Aspis-specific IgG and IgG4 in beekeepers. Clin Exp Allergy 1997;27:418-423.
80. Awazuhara H, Kawai H, Maruchi N. Major allergens in soybean and clinical significance of IgG4 antibodies investigated by IgE- and IgG4-immunoblotting with sera from soybean-sensitive patients. Clin Exp Allergy 1997;27:325-332.
81. Tang L, Benjaponpitak S, DeKruyff RH et al. Reduced prevalence of allergic disease in patients with multiple sclerosis is associated with enhanced IL-12 production. J Allergy Clin Immunol 1998;102:428-435.
82. Sher A, Jankovic D, Cheever A et al. An IL-12-based vaccine approach for preventing immunopathology in schistosomiasis. Ann NY Acad Sci 1996; 795:202-207.
83. Jacobson NG, Szabo SJ, Guler ML, et al. Regulation of interleukin-12 signaling during T helper phenotype development. Adv Exp Med Biol 1996;409: 61-73.
84. Grunewald SM, Werthmann A, Schnarr B, et al. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo. J Immunol 1998;160: 4004-4009.
85. Savelkoul HFJ, van Ommen R. Role of IL-4 in persistent IgE formation. Eur Respir J 1996;9(Suppl 22):67s-71s.
86. Roman M, Spiegelberg HL, Broide D, et al. Gene immunization for allergic disorders. Springer Sems Immunopathol 1997;19:223-232.
87. Muller U, Akdis CA, Fricker M, et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specifie T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998; 101:747-754.